1. Halloysite nanotubes-based hybrid silica monolithic spin tip for hydrophilic solid-phase extraction of sulbactam, cefoperazone, and cefuroxime in whole blood.
- Author
-
Xuan R, Shi B, Li D, Chen Y, Hou C, Jiang R, Guo M, Zhang Y, and Wang T
- Subjects
- Humans, Clay chemistry, Adsorption, Anti-Bacterial Agents blood, Anti-Bacterial Agents chemistry, Polyethyleneimine chemistry, Chromatography, High Pressure Liquid methods, Reproducibility of Results, Cefoperazone blood, Cefoperazone chemistry, Sulbactam blood, Sulbactam chemistry, Hydrophobic and Hydrophilic Interactions, Solid Phase Extraction methods, Silicon Dioxide chemistry, Nanotubes chemistry, Cefuroxime blood, Cefuroxime chemistry, Limit of Detection
- Abstract
In this study, we proposed a novel method utilizing polyethyleneimine (PEI)-modified halloysite nanotubes (HNTs)-based hybrid silica monolithic spin tip to analyze hydrophilic β-lactam antibiotics and β-lactamases inhibitors in whole blood samples for the first time. HNTs were incorporated directly into the hybrid silica monolith via a sol-gel method, which improved the hydrophilicity of the matrix. The as-prepared monolith was further modified with PEI by glutaraldehyde coupling reaction. It was found that the PEI-modified HNTs-based hybrid silica monolith enabled a large adsorption capacity of cefoperazone at 35.7 mg g
-1 . The monolithic spin tip-based purification method greatly reduced the matrix effect of whole blood samples and had a detection limit as low as 0.1 - 0.2 ng mL-1 . In addition, the spiked recoveries of sulbactam, cefuroxime, and cefoperazone in blank whole blood were in the range of 89.3-105.4 % for intra-day and 90.6-103.5 % for inter-day, with low relative standard deviations of 1.3-7.2 % and 4.9-10.5 %, respectively. This study introduces a new strategy for preparing nanoparticles incorporated in a hybrid silica monolith with a high adsorption capacity. Moreover, it offers a valuable tool to monitor sulbactam, cefoperazone, and cefuroxime in whole blood from pregnant women with the final aim of guiding their administration., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024. Published by Elsevier B.V.)- Published
- 2024
- Full Text
- View/download PDF